These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11303517)

  • 1. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinaemia with normal sweat test.
    Castellani C; Benetazzo MG; Tamanini A; Begnini A; Mastella G; Pignatti P
    J Med Genet; 2001 Mar; 38(3):202-5. PubMed ID: 11303517
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Many deltaF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation.
    Boyne J; Evans S; Pollitt RJ; Taylor CJ; Dalton A
    J Med Genet; 2000 Jul; 37(7):543-7. PubMed ID: 10970190
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis.
    Scotet V; De Braekeleer M; Audrézet MP; Lodé L; Verlingue C; Quéré I; Mercier B; Duguépéroux I; Codet JP; Moineau MP; Parent P; Férec C
    Clin Genet; 2001 Jan; 59(1):42-7. PubMed ID: 11168024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A continuing role for sweat testing in an era of newborn screening for cystic fibrosis.
    Kirk JM
    Clin Biochem; 2011 May; 44(7):487-488. PubMed ID: 22036339
    [No Abstract]   [Full Text] [Related]  

  • 6. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test.
    Castellani C; Bonizzato A; Mastella G
    J Med Genet; 1997 Apr; 34(4):297-301. PubMed ID: 9138152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis mutations in heterozygous newborns with hypertrypsinemia and low sweat chloride.
    Castellani C; Benetazzo MG; Bonizzato A; Pignatti PF; Mastella G
    Am J Hum Genet; 1999 Jan; 64(1):303-4. PubMed ID: 9915972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Bend J
    Kinderkrankenschwester; 2016 Dec; 35(12):466-467. PubMed ID: 30387970
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tests for cystic fibrosis.
    Davies JC
    Paediatr Respir Rev; 2006; 7 Suppl 1():S141-3. PubMed ID: 16798543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
    Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic trypsinogen and pancreatic secretory trypsin inhibitor gene mutations in neonatal hypertrypsinaemia.
    Patuzzo C; Castellani C; Sagramoso C; Gomez-Lira M; Bonamini D; Belpinati F; Dechecchi MC; Assael BM; Pignatti PF
    Eur J Hum Genet; 2003 Jan; 11(1):93-6. PubMed ID: 12529713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systematic neonatal screening].
    Guillot M; Travert G; Roussey M; Figarella C; Vidailhet M
    Arch Pediatr; 2001 Dec; 8 Suppl 5():833s-837s. PubMed ID: 11811052
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
    Keiles S; Koepke R; Parad R; Kharrazi M;
    J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 17. Sweat chloride testing: controversies and issues.
    Kharrazi M; Milla C; Wine J
    Lancet Respir Med; 2016 Aug; 4(8):605-607. PubMed ID: 27511631
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U; Moatter T
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
    Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
    Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.